State Street’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-10,189
| Closed | -$11K | – | 3915 |
|
|
2019
Q1 | $11K | Hold |
10,189
| – | – | ﹤0.01% | 3724 |
|
|
2018
Q4 | $8K | Sell |
10,189
-21,258
| -68% | -$32K | ﹤0.01% | 3744 |
|
|
2018
Q3 | $67K | Buy |
31,447
+1,752
| +6% | +$4.2K | ﹤0.01% | 3680 |
|
|
2018
Q2 | $69K | Buy |
29,695
+5,854
| +25% | +$17K | ﹤0.01% | 3662 |
|
|
2018
Q1 | $75K | Buy |
23,841
+3,174
| +15% | +$8.74K | ﹤0.01% | 3632 |
|
|
2017
Q4 | $85K | Buy |
20,667
+7,567
| +58% | +$32.9K | ﹤0.01% | 3612 |
|
|
2017
Q3 | $59K | Hold |
13,100
| – | – | ﹤0.01% | 3656 |
|
|
2017
Q2 | $44K | Sell |
13,100
-339,212
| -96% | -$1.41M | ﹤0.01% | 3604 |
|
|
2017
Q1 | $3.25M | Buy |
352,312
+11,041
| +3% | +$97K | ﹤0.01% | 2909 |
|
|
2016
Q4 | $2.63M | Buy |
341,271
+46,171
| +16% | +$424K | ﹤0.01% | 3001 |
|
|
2016
Q3 | $3.37M | Buy |
295,100
+30,261
| +11% | +$352K | ﹤0.01% | 2769 |
|
|
2016
Q2 | $3.26M | Buy |
264,839
+28,007
| +12% | +$340K | ﹤0.01% | 2845 |
|
|
2016
Q1 | $2.4M | Buy |
236,832
+14,518
| +7% | +$170K | ﹤0.01% | 2934 |
|
|
2015
Q4 | $5.01M | Buy |
222,314
+26,156
| +13% | +$536K | ﹤0.01% | 2535 |
|
|
2015
Q3 | $3.26M | Sell |
196,158
-24,525
| -11% | -$492K | ﹤0.01% | 2750 |
|
|
2015
Q2 | $4.92M | Buy |
220,683
+32,793
| +17% | +$809K | ﹤0.01% | 2625 |
|
|
2015
Q1 | $4.84M | Sell |
187,890
-3,514
| -2% | -$89.1K | ﹤0.01% | 2580 |
|
|
2014
Q4 | $4.16M | Buy |
191,404
+12,839
| +7% | +$263K | ﹤0.01% | 2660 |
|
|
2014
Q3 | $3.38M | Buy |
178,565
+15,991
| +10% | +$321K | ﹤0.01% | 2752 |
|
|
2014
Q2 | $3.79M | Buy |
162,574
+90,289
| +125% | +$2.23M | ﹤0.01% | 2739 |
|
|
2014
Q1 | $2.43M | Buy |
72,285
+8,766
| +14% | +$295K | ﹤0.01% | 2972 |
|
|
2013
Q4 | $1.88M | Buy |
63,519
+32,419
| +104% | +$594K | ﹤0.01% | 3098 |
|
|
2013
Q3 | $477K | Buy |
+31,100
| New | +$576K | ﹤0.01% | 3354 |
|
State Street's OMED Position: Q2 2019 in Review
State Street sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 10,189 shares — an estimated $11K sold.
State Street first reported a position in OMED in Q3 2013 and held it in 23 quarters. The position peaked at $5.01M in Q4 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.
- State Street reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- State Street sold 10,189 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $11K.
- State Street first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 23 quarters.
- State Street's OncoMed Pharmaceuticals, Inc. position peaked at $5.01M in Q4 2015.
- 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.
Based on State Street's 13F filing for Q2 2019, filed 14 Aug 2019.